NQO1 and cancer: NQO1 is overexpressed in most solid cancers (e.g., non-small cell lung, pancreatic, breast, and head and neck), with very low expression in normal cells/tissue (21, 22), and has the potential to be a promising therapeutic target for cancer treatment (23).